News On Japan

High demand weight-loss drug 'Wegovy' now covered by Japan's health insurance

TOKYO - Danish pharmaceutical giant Novo Nordisk's anti-obesity drug "Wegovy" is now covered by Japan's public health insurance scheme. Doctor's, however, are concerned about the long-term effects of this highly addictive weight-loss treatment, and whether worldwide supply shortages will stop it getting into the hands of people who need it most.

The World Obesity Federation warns that by 2025, one in five adults worldwide may be obese, with a third of them having severe obesity with a BMI over 35.

Wegovy leads to an approximate 10% weight reduction through weekly injections of 2.4 mg, as per research including data from Japan. It's a self-administered injection that works by suppressing appetite and stomach movement, aiding in obesity treatment.

Chiba University Hospital's Dr. Kei Ono highlights the scarcity of such obesity drugs globally, with countries like Germany imposing export bans. In the United States, Wegovy's insurance coverage was approved in 2021, and its sales have more than tripled compared to the same period last year.

Another high-demand drug is "Ozempic," originally a diabetes medication known for its appetite-suppressing effects and used off-label for weight loss. Dr. Walden, an expert in obesity treatment drugs, notes the popularity of Wegovy and Ozempic in their clinic, with many patients seeking weight loss for cosmetic reasons.

However, Dr. Walden also points out that these drugs are not a permanent solution and can lead to dependency. Priority should be given to diabetic patients, and there are concerns about drug shortages due to unprescribed use, similar to what happened in the U.S.

Koichi Nagata, suffering from obesity with a BMI exceeding 42, has struggled to lose weight despite efforts like cycling, diet control, and weight training. Wegovy offers hope for fat burning and metabolic improvement, but concerns about side effects remain.

Japan's Ministry of Health, Labour and Welfare has guidelines against prescribing these drugs for non-medical weight loss. Dr. Ono expresses concerns about potential misuse for diet purposes and the resulting supply shortages, affecting those in genuine need.

Additionally, Dr. Ono warns of potential side effects like nausea and acute pancreatitis, emphasizing the importance of following prescribed dosages and medical guidance.

News On Japan
POPULAR NEWS

The family of James "Weston" Higginbotham, a 20-year-old Auburn University student who disappeared during a family vacation in Japan, announced on June 7th that he has been found dead after a volunteer search-and-rescue group located his body in a mountainous area outside Kyoto, bringing a week-long multinational search to a tragic end.

Japan's Meteorological Agency announced on June 7th that the rainy season is believed to have begun in the Tokai and Kanto-Koshin regions, marking the seasonal shift to wetter weather across a broad area of the country.

Expectations for Japan are unusually high heading into the 2026 World Cup, with the team now aiming not merely to reach the knockout stage but to finally break through the Round of 16 and advance to the quarterfinals for the first time.

Residents in Nara Prefecture are celebrating after UNESCO's advisory body recommended the archaeological complex known as the Asuka-Fujiwara Ancient Capitals for inscription as a World Heritage site, bringing the historic birthplace of Japan's ancient state one step closer to international recognition.

A tropical depression is expected to move northward this weekend and could bring another round of heavy rain to parts of Japan, following a week in which Typhoon Jangmi (Typhoon No. 6) caused significant rainfall and left some areas vulnerable to further weather-related damage.

MEDIA CHANNELS
         

MORE Business NEWS

Rapid inflation and the weakening yen continue to squeeze household budgets across Japan, prompting renewed debate over the country's economic policies. Former Bank of Japan Governor Haruhiko Kuroda, who spearheaded the central bank's aggressive monetary easing campaign under Abenomics, argues that the overall economy remains on a positive trajectory and that wage growth is now exceeding inflation.

A court is set to hand down its verdict on August 28th in the trial of former Momuri president Shinji Tanimoto and his wife Shiori, who are accused of violating Japan's Attorney Act by illegally referring clients of the retirement agency service to lawyers.

Japan's household spending fell for the fifth consecutive month in April, highlighting continued pressure on consumers as rising prices and growing concerns over instability in the Middle East weighed on household budgets.

Japan's largest electronics retailer, Yamada Holdings, and Osaka-based Edion announced on June 5th that they have agreed to integrate their businesses, creating a group with annual sales of approximately 2.5 trillion yen as competition in the consumer electronics industry intensifies and companies seek new ways to boost growth in a shrinking domestic market.

Japan's real wages rose 1.9% in April from a year earlier, marking the fourth consecutive month of growth and the longest stretch of positive gains in about five years as this year's spring labor-management wage negotiations began feeding through into workers' paychecks.

Nissan Motor has begun accepting orders in Japan for the Murano sport utility vehicle, which is produced in the United States, marking one of the first uses of a new vehicle certification framework established following a tariff agreement between Japan and the United States.

Uber Japan unveiled its latest strategy for its mobility business, including its taxi-hailing app operations, as the company seeks to expand its presence in a market where ride-hailing app usage remains lower than in many other countries.

The Office of the United States Trade Representative (USTR) announced on June 2nd that it is considering imposing an additional 12.5% tariff on Japan, arguing that the country's measures to prevent the import of products made with forced labor are insufficient.